title: Regulatory issues: an academic viewpoint from Asia (ex-Japan).
abstract: Regulatory reforms, together with large patient pools and increasing numbers of well-trained clinicians, have facilitated the development of clinical trials in Asia. Current regulatory and ethical issues are discussed.
authors.affiliation: Department of Neurology, Singapore General Hospital, Singapore. gnrcc@sgh.com.sg
authors.forename: Christopher P L-H
authors.initials: CP
authors.lastname: Chen
mesh_terms: D000368:Aged; D001208:Asia; D002986:Clinical Trials as Topic / Q000941:ethics / Q000331:legislation & jurisprudence; D015140:Dementia, Vascular / Q000628:therapy; D026690:Ethics, Clinical; D033161:Government Regulation; D017408:Guidelines as Topic; D006801:Humans; D007400:Interprofessional Relations